pioglitazone hydrochloride
pioglitazone hydrochloride is listed in the FDA National Drug Code directory with 17 NDC codes, marketed under brand name including PIOGLITAZONE HYDROCHLORIDE. Available dosage forms: tablet, powder.
Drug details
- Generic Name
- pioglitazone hydrochloride
- Brand Names
- PIOGLITAZONE HYDROCHLORIDE
- Application Number
- ANDA200268
- Sponsor
- A-S Medication Solutions
- NDC Codes
- 17
- Dosage Forms
- TABLET, POWDER
- Routes
- ORAL
- Active Ingredients
- PIOGLITAZONE HYDROCHLORIDE
Indications and Usage
1 INDICATIONS AND USAGE Monotherapy and Combination Therapy Pioglitazone Tablets is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus in multiple clinical settings [see Clinical Studies (14) ] . Important Limitations of Use Pioglitazone Tablets exerts its antihyperglycemic effect only in the presence of endogenous insulin. Pioglitazone Tablets should not be used to treat type 1 diabetes or diabetic ketoacidosis, as it would not be effective in these settings. Use caution in patients with liver disease [see Warnings and Precautions (5.3) ] . Pioglitazone Tablets is a thiazolidinedione and an agonist for peroxisome proliferator-activated receptor (PPAR) gamma indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus in multiple clinical settings. ( 1, 14) Important Limitations of Use: Not for treatment of type 1 diabetes or diabetic ketoacidosis. ( 1 )